All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a registration for IMMIX BIOPHARMA, INC. on November 4, 2026.

Lobbying for IMMIX BIOPHARMA, INC. · Biopharmaceutical company

All filings by BROWNSTEIN HYATT FARBER SCHRECK, LLP · Everything IMMIX BIOPHARMA, INC. has reported

Filing · LD-1 registration Registration

Reporting period

4th Quarter 2026

Oct 1 - Dec 31 · Posted Nov 4, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Lobbyists on this filing 2

ADAM STEINMETZ New on this filing

Previously held: Policy Advisor - Committee on the Budget, United States House of Representatives
STEPHEN HOLLAND New on this filing

Previously held: Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 2

Pharmacy

Issues surrounding biopharmaceutical research, development, and regulatory policy and standards.

Health Issues

Issues surrounding biopharmaceutical research, development, and regulatory policy and standards.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.